Gyki-52466 is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target glutamate receptor 1, glutamate receptor 4, glutamate receptor 3, and glutamate receptor 2.
Trade Name |
|
Common Name |
Gyki-52466 |
Indication |
|
Drug Class |
|